Findings from previous preclinical and clinical studies have indicated that NLRP3 inflammasome-driven pathways might be involved in numerous neuropsychiatric disorders including neuroinflammation-induced depression [14, 27–30]. This evidence concerns the gene NLRP3 and depressive disorder.